P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL. (23rd June 2022) - Zinzani, P. L.; Özcan, M.; Sapunarova, K.; Jurczak, W.; Hamed, A.; Bouabdallah, K.; Saydam, G.; Geissler, K.; Szomor, Á.; Lazaroiu, M.; Salar, A.; Tempescul, A.; et al.